MaxCyte base_Aktie

MaxCyte base_Umsatz 2025

MaxCyte base_Umsatz

37.13 number_format_mio USD

components_StockPageHeader__3

MXCT

components_StockPageHeader__4

US57777K1060

components_StockPageHeader__5

A2AGVE

pages_kennzahlen_[key]_[isin]__46

pages_kennzahlen_[key]_[isin]__70

components_DataTable__24components_DataTable__0components_DataTable__2
2030e210.6814,96
2029e135.9223,20
2028e84.9537,11
2027e52.1960,41
2026e42.6273,97
2025e37.1384,91
202438.6381,62
202341.2988,51
202244.2688,48
202133.8989,26
202026.1789,42
201921.6288,44
201816.6788,96
201713.9989,56
201612.2789,32
20159.2988,91
20147.1686,73
20136.8188,11
20125.0683,60

components_charts_RevenueChart_0

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_RevenueChart_8
components_charts_RevenueChart_10
components_charts_RevenueChart_9
Details
components_charts_RevenueChart_13

MaxCyte components_charts_RevenueChart_15

components_charts_RevenueChart_14MaxCyte components_charts_RevenueChart_8MaxCyte components_charts_RevenueChart_10MaxCyte components_charts_RevenueChart_9
2030e210.68 number_format_mio undefined0 undefined0 undefined
2029e135.92 number_format_mio undefined13.59 number_format_mio undefined0 undefined
2028e84.95 number_format_mio undefined-8.5 number_format_mio undefined0 undefined
2027e52.19 number_format_mio undefined-33.98 number_format_mio undefined-41.71 number_format_mio undefined
2026e42.62 number_format_mio undefined-53.12 number_format_mio undefined-45.45 number_format_mio undefined
2025e37.13 number_format_mio undefined-55.07 number_format_mio undefined-45.27 number_format_mio undefined
202438.63 number_format_mio undefined-51.2 number_format_mio undefined-41.06 number_format_mio undefined
202341.29 number_format_mio undefined-48.3 number_format_mio undefined-37.92 number_format_mio undefined
202244.26 number_format_mio undefined-27.36 number_format_mio undefined-23.57 number_format_mio undefined
202133.89 number_format_mio undefined-18.19 number_format_mio undefined-19.08 number_format_mio undefined
202026.17 number_format_mio undefined-11.06 number_format_mio undefined-11.82 number_format_mio undefined
201921.62 number_format_mio undefined-12.42 number_format_mio undefined-12.9 number_format_mio undefined
201816.67 number_format_mio undefined-8.42 number_format_mio undefined-8.87 number_format_mio undefined
201713.99 number_format_mio undefined-9.29 number_format_mio undefined-9.92 number_format_mio undefined
201612.27 number_format_mio undefined-2.72 number_format_mio undefined-3.85 number_format_mio undefined
20159.29 number_format_mio undefined-760,000 undefined-3.52 number_format_mio undefined
20147.16 number_format_mio undefined-1.28 number_format_mio undefined-6.3 number_format_mio undefined
20136.81 number_format_mio undefined-800,000 undefined-2.86 number_format_mio undefined
20125.06 number_format_mio undefined-1.96 number_format_mio undefined-3.89 number_format_mio undefined

components_charts_MarginsChart_0

components_charts_MarginsChart_18
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_MarginsChart_15
components_charts_MarginsChart_17
components_charts_MarginsChart_16
Details
components_charts_MarginsChart_19

MaxCyte components_charts_MarginsChart_21

MaxCyte components_charts_MarginsChart_15MaxCyte components_charts_MarginsChart_16MaxCyte components_charts_MarginsChart_17MaxCyte components_charts_MarginsChart_16
2030e81.62 %0 %0 %
2029e81.62 %10 %0 %
2028e81.62 %-10 %0 %
2027e81.62 %-65.12 %-79.92 %
2026e81.62 %-124.63 %-106.64 %
2025e81.62 %-148.31 %-121.93 %
202481.62 %-132.54 %-106.29 %
202388.51 %-116.98 %-91.85 %
202288.48 %-61.82 %-53.25 %
202189.26 %-53.67 %-56.3 %
202089.42 %-42.26 %-45.17 %
201988.44 %-57.45 %-59.67 %
201888.96 %-50.51 %-53.21 %
201789.56 %-66.4 %-70.91 %
201689.32 %-22.17 %-31.38 %
201588.91 %-8.18 %-37.89 %
201486.73 %-17.88 %-87.99 %
201388.11 %-11.75 %-42 %
201283.6 %-38.74 %-76.88 %

MaxCyte Aktienanalyse

pages_kennzahlen_[key]_[isin]__1

MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.

pages_kennzahlen_[key]_[isin]__85

pages_kennzahlen_[key]_[isin]__71

pages_dividenden_[isin]_index__2

components_kpi_RevenueFaqs_0

components_kpi_RevenueFaqs_1

components_kpi_RevenueFaqs_2

components_kpi_RevenueFaqs_3

components_kpi_RevenueFaqs_4

components_kpi_RevenueFaqs_5

components_kpi_RevenueFaqs_6

components_kpi_RevenueFaqs_7

components_kpi_RevenueFaqs_8

components_kpi_RevenueFaqs_9

components_kpi_RevenueFaqs_10

components_kpi_RevenueFaqs_11

components_kpi_RevenueFaqs_12

components_kpi_RevenueFaqs_13

components_kpi_RevenueFaqs_14

components_kpi_RevenueFaqs_15

components_kpi_RevenueFaqs_16

components_kpi_RevenueFaqs_17

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von MaxCyte kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

components_kpi_Savingsplan_0